INCB047986

· Incyte Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INCB047986, covering 2015-02-23 to 2015-02-23. Get the full timeline:

Most recent: Clinical Trial Update: INCB047986 in Rheumatoid Arthritis [Phase 2]